Vasopressin but not oxytocin enhances cortical arousal: an integrative hypothesis on behavioral effects of neurohypophyseal hormones
Abstract
Behavioral changes after administration of the neurohypophyseal hormones vasopressin and oxytocin can be observed in animal and man. Several groups attempted to specify these changes in terms of memory or attention processing enhancement for vasopressin and amnesic properties for oxytocin. These interpretations, however, were targets for recent criticism. In a double-blind between-subject comparison with male volunteers receiving arginine-vasopressin (AVP), oxytocin or placebo intranasally prior to the experimental session, we tried to develop an alternative hypothesis on the basis of behavioral and EEG measures. At the beginning of the session subjects had to learn a list of 25 unrelated nouns within five trials. Recall was assessed 1 h later. Neither learning nor long-term recall were affected by peptide treatments. In a second vigilance task subjects had to covertly count eight series of tone pips. Averaged auditory evoked potentials to these tones showed the expected habituation during the course of the task within all three groups. Vasopressin-treated subjects, however, displayed significantly higher amplitudes of the vertex potential as compared to the other treatment groups. AVP effects were most prominent with the longest interstimulus interval. No influences on heart rate or blood pressure were found. Results indicate that vasopressin induces an enhancement of stimulus-related phasic cortical arousal, and that in this respect oxytocin has no effect.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Intranasal vasopressin increased the amplitude of several components of late event-related potentials, in particular P3, which reflects higher cognitive and attention processing.
“IN-AVP increased the amplitude of several components of the late ERPs, in particular the amplitude of P3, which reflects a higher level of cognitive and attention processing (Born et al. 1986; Fehm-Wolfsdorf et al. 1988; Naumann et al. 1991; Pietrowsky et al. 1989).”
From A precision medicine approach to oxytocin trials (2017) · cites this paper as Fehm-Wolfsdorf et al. 1988
Cites
Baddeley, A., & Baddeley (1976) · Cited by 697 · see citing works
Effect of Changes in Stimulus Frequency and Intensity on Habituation of the Human Vertex Potential
Butler, R. A. (1968) · The Journal of the Acoustical Society of America · doi:10.1121/1.1911233 · Cited by 246 · see citing works
Central target for the behavioural effects of vasopressin neuropeptides
de Wied, D., Gaffori, O., van Ree, J. M., & de Jong, W. (1984) · Nature · doi:10.1038/308276a0 · Cited by 243 · see citing works
Vasopressor receptor antagonist prevents behavioural effects of vasopressin
Moal, M. L., Koob, G. F., Koda, L. Y., Bloom, F. E., Manning, M., Sawyer, W. H., & Rivier, J. (1981) · Nature · doi:10.1038/291491a0 · Cited by 154 · see citing works
Ettenberg, A., VANDERKOOY, D., Moal, M. L., Koob, G. F., & Bloom, F. E. (1983) · Behavioural Brain Research · doi:10.1016/0166-4328(83)90024-4 · Cited by 147 · see citing works
A critique of the vasopressin-memory hypothesis
Sahgal, A. (1984) · Psychopharmacology · doi:10.1007/bf00464785 · Cited by 145 · see citing works
Neuropeptides and psychosomatic processes
Endröczi, E., & Fidia, F. (1983) · Akadémiai Kiadó eBooks · Cited by 91 · see citing works
Human memory and neurohypophyseal hormones: Opposite effects of vasopressin and oxytocin
Fehm‐Wolfsdorf, G., Jan Born, A., Voigt, K., & Fehm, H. (1984) · Psychoneuroendocrinology · doi:10.1016/0306-4530(84)90007-6 · Cited by 91 · see citing works
Self-citationWhat is the importance of vasopressin in memory processes?
Gash, D. M., & Thomas, G. J. (1983) · Trends in Neurosciences · doi:10.1016/0166-2236(83)90089-9 · Cited by 90 · see citing works
Moal, M. L., Dantzer, R., Mormède, P., Baduel, A., Lebrun‐Frénay, C., Ettenberg, A., van der Kooy, D., Wenger, J. R., Deyo, S. N., Koob, G. F., et al. (1984) · Psychoneuroendocrinology · doi:10.1016/0306-4530(84)90042-8 · Cited by 88 · see citing works
Vasopressin and electrophysiological signs of attention in man
Born, J., Fehm-Wolfsdorf, G., Lutzenberger, W., Voigt, K. H., & Fehm, H. L. (1986) · Peptides · doi:10.1016/0196-9781(86)90211-1 · Cited by 69 · see citing works
Self-citationVasopressin analog (DDAVP) improves memory in human males
Beckwith, B. E., Till, R. E., & Schneider, V. A. (1984) · Peptides · doi:10.1016/0196-9781(84)90028-7 · Cited by 61 · see citing works
The importance of vasopressin in memory
de Wied, D. (1984) · Trends in Neurosciences · doi:10.1016/s0166-2236(84)80157-5 · Cited by 55 · see citing works
The effect of vasopressin on memory in the healthy elderly
Nebes, R. D., Reynolds, C. F., & Horn, L. C. (1984) · Psychiatry Research · doi:10.1016/0165-1781(84)90107-0 · Cited by 52 · see citing works
Vasopressin analogue (ddavp) facilitates recall of narrative prose.
Beckwith, B. E., Petros, T. V., Bergloff, P. J., & Staebler, R. J. (1987) · Behavioral Neuroscience · doi:10.1037//0735-7044.101.3.429 · Cited by 30 · see citing works
Millar, K., Jeffcoate, W. J., & Walders, C. P. (1987) · Psychological Medicine · doi:10.1017/s0033291700024879 · Cited by 25 · see citing works
Vasopressin analogue ({ddavp}) facilitates recall of narrative prose.
Beckwith, B. E., Petros, T. V., Bergloff, P. J., et al. (1987) · Behavioral Neuroscience · doi:10.1037/0735-7044.101.3.429 · Cited by 25 · see citing works
Behavioral Effects of Vasopressin
Fehm‐Wolfsdorf, G., Jan Born, A., Voigt, K., & Fehm, L. (2008) · Neuropsychobiology · doi:10.1159/000118050 · Cited by 22 · see citing works
Self-citationVasopressin does not enhance memory processes: A study in human twins
Fehm‐Wolfsdorf, G., Jan Born, A., Elbert, T. R., Voigt, K., & Fehm, H. L. (1985) · Peptides · doi:10.1016/0196-9781(85)90055-5 · Cited by 20 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Heinrichs, M., Baumgartner, T., Kirschbaum, C., & Ehlert, U. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00465-7 · Cited by 2,091 · see citing works
The oxytocin receptor: from intracellular signaling to behavior
Jurek, B., & Neumann, I. D. (2018) · Physiological Reviews · doi:10.1152/physrev.00031.2017 · Cited by 999 · see citing works
Oxytocin Increases Retention of Social Cognition in Autism
Hollander, E., Bartz, J., Chaplin, W., Phillips, A., Sumner, J., Soorya, L., Anagnostou, E., & Wasserman, S. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.030 · Cited by 693 · see citing works
Human Leptin Levels Are Pulsatile and Inversely Related to Pituitary–Ardenal Function
Licinio, J., Mantzoros, C., Negrão, A. B., Cizza, G., Wong, M.-L., Bongiorno, P. B., Chrousos, G. P., Karp, B., Allen, C., Flier, J. S., et al. (1997) · Nature Medicine · doi:10.1038/nm0597-575 · Cited by 632 · see citing works
The Peptide That Binds: A Systematic Review of Oxytocin and its Prosocial Effects in Humans
MacDonald, K., & MacDonald, T. M. (2010) · Harvard Review of Psychiatry · doi:10.3109/10673220903523615 · Cited by 585 · see citing works
Ferris, C. F., Melloni Jr, R. H., Koppel, G., Perry, K. W., Fuller, R. W., & Delville, Y. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-11-04331.1997 · Cited by 495 · see citing works
Prosocial effects of oxytocin and clinical evidence for its therapeutic potential
Striepens, N., Kendrick, K. M., Maier, W., & Hurlemann, R. (2011) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2011.07.001 · Cited by 283 · see citing works
Post-learning intranasal oxytocin modulates human memory for facial identity
Savaskan, E., Ehrhardt, R., Schulz, A., Walter, M., & Schächinger, H. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.12.004 · Cited by 262 · see citing works
Intranasal oxytocin attenuates the cortisol response to physical stress: a dose-response study
Cardoso, C., Ellenbogen, M. A., Orlando, M. A., Bacon, S. L., & Joober, R. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.07.013 · Cited by 187 · see citing works
Wigton, R., Radua, J., Allen, P., Averbeck, B., Meyer-Lindenberg, A., McGuire, P., Shergill, S. S., & Fusar-Poli, P. (2015) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.130289 · Cited by 179 · see citing works
Pitman, R. K., Orr, S. P., & Lasko, N. B. (1993) · Psychiatry Research · doi:10.1016/0165-1781(93)90035-f · Cited by 150 · see citing works
A psychobiological rationale for oxytocin in the treatment of posttraumatic stress disorder
Olff, M., Langeland, W., Witteveen, A., & Denys, D. (2010) · CNS Spectrums · doi:10.1017/s109285290000047x · Cited by 135 · see citing works
Overview of human oxytocin research
Kendrick, K. M., Guastella, A. J., & Becker, B. (2017) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2017_19 · Cited by 121 · see citing works
Neuropsychological effects of vasopressin in healthy humans
Born, J., Pietrowsky, R., & L. Fehm, H. (1999) · Progress in brain research · doi:10.1016/s0079-6123(08)61595-2 · Cited by 42 · see citing works
A precision medicine approach to oxytocin trials
Andari, E., Hurlemann, R., & Young, L. J. (2017) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2017_29 · Cited by 40 · see citing works
McEwen (2004) · doi:10.1016/s1054-3589(04)50016-9 · Cited by 22 · see citing works
Vasopressin and cognitive processes: Two event-related potential studies
Naumann, E., Bartussek, D., Kaiser, W., & Fehm-Wolfsdorf, G. (1991) · Peptides · doi:10.1016/0196-9781(91)90223-c · Cited by 15 · see citing works
Self-citationPietrowsky, R., Born, J., Fehm-Wolfsdorf, G., & Fehm, H. L. (1989) · Biological Psychology · doi:10.1016/0301-0511(89)90003-3 · Cited by 8 · see citing works
Self-citation
- Authors
- Fehm-Wolfsdorf, G., Bachholz, G., Born, J., Voigt, K., & Fehm, H. L.
- Affiliations
- Universität Ulm (DE)
- Venue
- Psychopharmacology
- Published
- 1988-04
- Volume
- 94
- Issue
- 4
- Pages
- 496-500
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2066465114
- Cited by
- 67
- References
- 19
- Citations by year
- 2024: 2 · 2022: 1 · 2020: 2 · 2019: 1 · 2018: 2 · 2017: 3 · 2016: 1 · 2015: 1 · 2014: 3 · 2013: 2 · 2012: 2
- FWCI
- 6.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Social Psychology › Neuroendocrine regulation and behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- vasopressin, oxytocin, neurohypophyseal hormones, cortical arousal, vertex potential, auditory evoked potentials, sustained attention, memory, intranasal administration, habituation, interstimulus interval
- MeSH terms
- Adult, Arousal, Blood Pressure, Evoked Potentials, Auditory, Heart Rate, Humans, Learning, Male, Memory, Oxytocin, Vasopressins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review